Long-Acting Injectable: An Exciting New Option for HIV Prevention
Alex Rinehart, PhD, explains how the development of a long-acting injectable offers a new preventive option for HIV.
Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains how the development of a long-acting injectable could potentially offer a new preventive option for individuals at risk for HIV.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Recent Videos
Related Content
